Status:

COMPLETED

Effects of Chronic Smoking on Circulating Endothelial and Platelet-derived Microparticle

Lead Sponsor:

Kurume University

Conditions:

Atherosclerosis

Eligibility:

MALE

20-40 years

Phase:

EARLY_PHASE1

Brief Summary

The investigators hypothesized that circulating EMP is a useful surrogate marker of early stage of endothelial damage. To determine the effects of chronic smoking on circulating EMP, from healthy volu...

Eligibility Criteria

Inclusion

  • healthy individuals who have no coronary risk factors

Exclusion

  • hypertension
  • dyslipidemia
  • chronic kidney disease
  • liver dysfunction
  • obesity (BMI\>25.0)
  • cerebrovascular disease
  • other severe systemic diseases (cancer, inflammatory diseases, etc)

Key Trial Info

Start Date :

November 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2010

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00795249

Start Date

November 1 2008

End Date

November 1 2010

Last Update

June 23 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kurume University Hospital

Kurume, Fukuoka, Japan, 830-0011

Effects of Chronic Smoking on Circulating Endothelial and Platelet-derived Microparticle | DecenTrialz